Algert Global’s Cross Country Healthcare CCRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72,284
| Closed | -$1.31M | – | 1192 |
|
|
2024
Q4 | $1.31M | Buy |
72,284
+26,623
| +58% | +$484K | 0.03% | 725 |
|
|
2024
Q3 | $614K | Sell |
45,661
-16,513
| -27% | -$222K | 0.02% | 861 |
|
|
2024
Q2 | $860K | Buy |
62,174
+4,751
| +8% | +$65.7K | 0.03% | 723 |
|
|
2024
Q1 | $1.08M | Buy |
57,423
+29,463
| +105% | +$552K | 0.04% | 594 |
|
|
2023
Q4 | $633K | Hold |
27,960
| – | – | 0.03% | 747 |
|
|
2023
Q3 | $693K | Buy |
+27,960
| New | +$693K | 0.03% | 647 |
|
|
2023
Q1 | – | Sell |
-15,717
| Closed | -$418K | – | 1150 |
|
|
2022
Q4 | $418K | Sell |
15,717
-98,584
| -86% | -$2.62M | 0.02% | 861 |
|
|
2022
Q3 | $3.24M | Buy |
114,301
+17,060
| +18% | +$484K | 0.2% | 131 |
|
|
2022
Q2 | $2.03M | Buy |
97,241
+30,080
| +45% | +$627K | 0.15% | 184 |
|
|
2022
Q1 | $1.46M | Buy |
+67,161
| New | +$1.46M | 0.1% | 364 |
|
|
2021
Q4 | – | Sell |
-13,514
| Closed | -$287K | – | 987 |
|
|
2021
Q3 | $287K | Buy |
13,514
+1,414
| +12% | +$30K | 0.04% | 777 |
|
|
2021
Q2 | $200K | Buy |
+12,100
| New | +$200K | 0.07% | 356 |
|
|
2017
Q2 | – | Sell |
-83,285
| Closed | -$1.2M | – | 300 |
|
|
2017
Q1 | $1.2M | Buy |
83,285
+3,955
| +5% | +$56.8K | 0.32% | 134 |
|
|
2016
Q4 | $1.24M | Buy |
79,330
+47,335
| +148% | +$739K | 0.35% | 113 |
|
|
2016
Q3 | $377K | Buy |
31,995
+8,238
| +35% | +$97.1K | 0.11% | 269 |
|
|
2016
Q2 | $331K | Hold |
23,757
| – | – | 0.13% | 264 |
|
|
2016
Q1 | $276K | Buy |
23,757
+7,063
| +42% | +$82.1K | 0.1% | 293 |
|
|
2015
Q4 | $274K | Buy |
+16,694
| New | +$274K | 0.13% | 252 |
|
|
2014
Q1 | – | Sell |
-172,098
| Closed | -$1.72M | – | 322 |
|
|
2013
Q4 | $1.72M | Buy |
172,098
+122,566
| +247% | +$1.22M | 0.46% | 74 |
|
|
2013
Q3 | $299K | Buy |
49,532
+13,444
| +37% | +$81.2K | 0.09% | 272 |
|
|
2013
Q2 | $186K | Buy |
+36,088
| New | +$186K | 0.06% | 250 |
|